DekaBank Deutsche Girozentrale
AMLX icon

DekaBank Deutsche Girozentrale’s Amylyx Pharmaceuticals AMLX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-83,000
Closed -$1.22M – 1442
2023
Q4 		$1.22M Buy
83,000
+50,000
+152% +$766K ﹤0.01% 867
2023
Q3 		$610K Hold
33,000
– – ﹤0.01% 973
2023
Q2 		$692K Hold
33,000
– – ﹤0.01% 955
2023
Q1 		$914K Buy
+33,000
New +$1.15M ﹤0.01% 890

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AMLX Position: Q1 2024 in Review

DekaBank Deutsche Girozentrale sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2024, closing a stake of 83,000 shares — an estimated $1.22M sold.

DekaBank Deutsche Girozentrale first reported a position in AMLX in Q1 2023 and held it in 4 quarters. The position peaked at $1.22M in Q4 2023. 143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • DekaBank Deutsche Girozentrale reported no remaining Amylyx Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 83,000 Amylyx Pharmaceuticals shares in Q1 2024, an estimated $1.22M.
  • DekaBank Deutsche Girozentrale first reported a position in Amylyx Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Amylyx Pharmaceuticals position peaked at $1.22M in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.